Federal Judge Appoints Moze Cowper to Plaintiffs’ Executive Committee in Boston Scientific Spinal Cord Stimulator MDL

Federal Judge Appoints Moze Cowper to Plaintiffs’ Executive Committee in MDL-3181

LOS ANGELES, CA, UNITED STATES, August 17, 2026 /EINPresswire.com/ -- Cowper Law LLP announced today that Managing Partner Moze Cowper has been appointed by United States District Judge Josephine L. Staton to serve on the Plaintiffs’ Executive Committee (“PEC”) in the recently established multi-district litigation involving Boston Scientific Corporation’s spinal cord stimulator products.

The litigation, In re: Boston Scientific Corporation Spinal Cord Stimulator Products Liability Litigation, MDL No. 3181, Case No. 2:26-ml-03181-JLS-E, is pending in the United States District Court for the Central District of California before Judge Staton. In Pretrial Order No. 2, entered August 13, 2026, Judge Staton appointed Cowper as one of four attorneys to the Plaintiffs’ Executive Committee. The PEC will work with court-appointed Co-Lead Counsel to coordinate and manage plaintiffs’ pretrial activities, participate in and chair litigation committees, assign and oversee projects, and perform other work necessary to advance the litigation.

“I am honored that Judge Staton has entrusted me with this responsibility,” said Cowper. “Spinal cord stimulators are implanted in patients who are often already living with significant and debilitating chronic pain. When a patient agrees to have a medical device surgically implanted in his or her body, that patient is placing an extraordinary amount of trust in the company that designed, manufactured and sold that device. Our job in this litigation will be to determine whether that trust was justified and, where patients have been injured, to hold the responsible parties accountable.”

Problems Associated With Spinal Cord Stimulators
Spinal cord stimulators are surgically implanted medical devices designed to treat chronic pain by delivering electrical impulses to the spinal cord. Although these devices can provide meaningful relief for some patients, spinal cord stimulation systems also carry significant potential risks and complications. Reported problems associated with SCS systems include lead migration, lead breakage, device and battery failure, loss of effective stimulation, unintended or painful overstimulation, electrical and hardware malfunctions, infection, and the need for revision or explant surgery. FDA adverse-event reports involving Boston Scientific devices have described, among other issues, lead migration accompanied by pain and overstimulation, inadequate stimulation despite repeated reprogramming, and implanted pulse generators requiring surgical replacement.

The lawsuits consolidated in the MDL allege that patients implanted with Boston Scientific spinal cord stimulation systems suffered serious injuries and complications associated with the devices. The litigation will examine, among other issues, the design, manufacture, testing, labeling, warnings and performance of the devices, as well as Boston Scientific’s knowledge of reported problems associated with its spinal cord stimulation systems. Boston Scientific is expected to contest plaintiffs’ allegations, and no determination of liability has been made.

“This litigation is ultimately about patients,” Cowper said. “These are people who turned to spinal cord stimulation because they were searching for relief from chronic pain. For patients who instead experienced device failures, additional pain, complications or another surgery to revise or remove the device, the consequences can be profound. I look forward to working with an exceptional group of lawyers from across the country to find out what happened and to seek justice for the people who have been harmed.”

About the Appointment
Judge Staton’s August 13, 2026 order established a leadership structure consisting of three Co-Lead Counsel, Plaintiffs’ Liaison Counsel, a four-member Plaintiffs’ Executive Committee, a Plaintiffs’ Steering Committee and a Leadership Development Committee.

Cowper was appointed to the four-member Executive Committee along with Ashleigh Raso of Nigh Goldenberg Raso & Vaughn, Richard Hood of The Wilhite Law Firm, and Trevor B. Rockstad of Davis & Crump, P.C. The Court directed the Executive Committee to support Co-Lead Counsel in the overall coordination and management of plaintiffs’ pretrial activities, work with other leadership committees to assign and support litigation projects, and chair and participate in committees established by Co-Lead Counsel.

About Moze Cowper and Cowper Law
Moze Cowper is the Managing Partner of Cowper Law LLP, a Los Angeles-based plaintiffs’ law firm representing individuals and families in complex product liability, medical device and catastrophic injury litigation. Cowper has extensive experience litigating cases against major medical-device manufacturers and other multinational corporations, with a particular focus on cases involving allegedly defective medical technologies and the patients injured by them.
Cowper Law is headquartered in Los Angeles, California.

Media Contact:
Cowper Law LLP
12301 Wilshire Boulevard, Suite 303
Los Angeles, California 90025
(877) 529-3707

Kelly O'Connor
Cowper Law LLP
+1 8775293707
email us here